Discover, develop and commercialise Artificial Amino Acid based medicines and diagnostics to treat patients with autoimmune and genetic diseases with the greatest unmet medical needs where current therapies are inadequate.
Contact UsThe A3SMO® Platform - the breakthrough molecular solution for the custom design of self-assembling artificial amino acid-based small molecules. It increases the drug-likeness of the molecules and creates first-in-class medicines to treat patients with major unmet clinical needs.